Published in Scand J Infect Dis on January 01, 1989
White blood cell counts and malaria. J Infect Dis (2005) 3.46
Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis (2009) 2.92
Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev (2013) 2.05
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 1.98
Discriminating malaria from dengue fever in endemic areas: clinical and biological criteria, prognostic score and utility of the C-reactive protein: a retrospective matched-pair study in French Guiana. PLoS Negl Trop Dis (2013) 0.85
Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation. Malar J (2007) 0.81
Leukogram Profile and Clinical Status in vivax and falciparum Malaria Patients from Colombia. J Trop Med (2015) 0.75
Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol (1981) 2.03
Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis (2002) 2.02
[Tetanus with a deep wound?]. Lakartidningen (1994) 1.92
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health (1996) 1.65
Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Trans R Soc Trop Med Hyg (1992) 1.63
The concentration of chloroquine in serum during short and long term malaria prophylaxis with standard and 'double' dosage in non-immunes: clinical implications. Ann Trop Med Parasitol (1979) 1.51
Are white blood cell count, platelet count, erythrocyte sedimentation rate and C-reactive protein useful in the diagnosis of septicaemia and endocarditis? Scand J Infect Dis (1986) 1.44
Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis. Bull World Health Organ (1987) 1.43
[False safety with homeopathic agents. Swedes became ill with malaria in spite of prophylaxis]. Lakartidningen (1995) 1.38
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop. J Travel Med (2003) 1.27
A case-control study in northern Liberia of Plasmodium falciparum malaria in haemoglobin S and beta-thalassaemia traits. Ann Trop Med Parasitol (1983) 1.24
Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum. Trop Med Parasitol (1986) 1.22
Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper. Ther Drug Monit (1985) 1.21
Different malaria control activities in an area of Liberia--effects on malariometric parameters. Ann Trop Med Parasitol (1985) 1.19
Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis. Br Med J (Clin Res Ed) (1987) 1.08
Effect of different fractions of heparin on Plasmodium falciparum merozoite invasion of red blood cells in vitro. Am J Trop Med Hyg (1992) 1.08
Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit (1985) 1.05
The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza. Scand J Infect Dis (1989) 1.04
Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ (1989) 1.03
Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1981) 1.02
Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid. J Infect Dis (1979) 1.01
Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene Pfmdr1. Trans R Soc Trop Med Hyg (1996) 1.01
Sulfadoxine assay using capillary blood samples dried on filter paper--suitable for monitoring of blood concentrations in the field. Ther Drug Monit (1987) 1.00
Painless venepuncture in the field. Trans R Soc Trop Med Hyg (1991) 1.00
Standard and reduced doses of sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum in Tanzania, with determination of drug concentrations and susceptibility in vitro. Trans R Soc Trop Med Hyg (1991) 0.98
Evaluation of three qualitative tests for detection of chloroquine in urine--agreement with plasma concentrations determined with liquid chromatography. Ann Trop Med Parasitol (1986) 0.98
Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar). Br Med J (Clin Res Ed) (1984) 0.97
Reliability of Dill-Glazko test. Lancet (1985) 0.97
Malaria parasites and chloroquine concentrations in Tanzanian schoolchildren. Trop Med Parasitol (1994) 0.96
Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol (2004) 0.96
Comparison of 3, 5 and 7 days' treatment with Quinimax for falciparum malaria in Guinea-Bissau. Trans R Soc Trop Med Hyg (1997) 0.94
Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine. Bull World Health Organ (1994) 0.94
The working capacity of Liberian males: a comparison between urban and rural populations in relation to malaria. Ann Trop Med Parasitol (1981) 0.92
Susceptibility of Plasmodium falciparum to quinine in vitro: effects of drug concentrations and time of exposure. Trans R Soc Trop Med Hyg (1995) 0.92
High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr (1988) 0.92
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clin Pharmacol Ther (1999) 0.91
EBV specific killer T cells and serologic responses after onset of infectious mononucleosis. J Clin Lab Immunol (1978) 0.90
Standard and reduced doses of mefloquine for treatment of Plasmodium falciparum in Tanzania: whole blood concentrations in relation to adverse reactions, in vivo response, and in vitro susceptibility. Am J Trop Med Hyg (1991) 0.90
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda. Afr Health Sci (2006) 0.90
Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis. Trans R Soc Trop Med Hyg (1990) 0.89
Is chloroquine-resistant Plasmodium falciparum malaria emerging in Senegal or The Gambia? Trans R Soc Trop Med Hyg (1987) 0.89
Does chloroquine contribute to the risk of serious adverse reactions to fansidar? Lancet (1985) 0.89
Monthly antimalarial chemotherapy to children in a holoendemic area of Liberia. Ann Trop Med Parasitol (1986) 0.88
Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects. Eur J Clin Pharmacol (1986) 0.87
Chloroquine resistant Plasmodium falciparum malaria in Guinea-Bissau. Trans R Soc Trop Med Hyg (1991) 0.86
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation. Acta Trop (2006) 0.86
Long-term exposure of Trypanosoma brucei gambiense to pentamidine in vitro. Trans R Soc Trop Med Hyg (1994) 0.84
Mass proguanil prophylaxis. Lancet (1987) 0.83
Intestinal parasites in refugees and asylum seekers entering the Stockholm area, 1987-88: evaluation of routine stool screening. Scand J Infect Dis (1994) 0.83
Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro. Trans R Soc Trop Med Hyg (1992) 0.82
Plasma pentamidine concentrations vary between individuals with Pneumocystis carinii pneumonia and the drug is actively secreted by the kidney. J Antimicrob Chemother (1994) 0.82
Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania. Ann Trop Med Parasitol (1986) 0.82
High-performance liquid chromatographic method for the enantioselective analysis of mefloquine in plasma and urine. J Chromatogr B Biomed Appl (1994) 0.81
Malaria prophylaxis and epilepsy. BMJ (1988) 0.81
Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized. Trop Med Int Health (1998) 0.81
Serum and erythrocyte concentrations of chloroquine in patients with acute diarrhoea. Ann Trop Med Parasitol (1982) 0.80
Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation. Pharmacol Toxicol (1994) 0.80
Plasma concentrations of sulfadoxine-pyrimethamine, mefloquine and its main metabolite after regular malaria prophylaxis for two years. Trans R Soc Trop Med Hyg (1991) 0.80
Aberrant atrioventricular conduction triggered by antimalarial prophylaxis with mefloquine. Lancet (1997) 0.80
Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness. Br J Clin Pharmacol (1995) 0.80
Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine (2005) 0.79
Diagnosis of fever in Africa. Lancet (1998) 0.79
Malaria prophylaxis when visiting areas of East Africa with chloroquine resistance. Lancet (1981) 0.79
Recent cases of falciparum malaria imported to Europe from Goa, India, December 2006-January 2007. Euro Surveill (2007) 0.78
Immunogenicity of delayed TBE-vaccine booster. Vaccine (2011) 0.78
Proguanil for malaria prophylaxis. Lancet (1983) 0.78
Serum Q fever antibodies in Swedish UN soldiers in Cyprus--reflecting a domestic or foreign disease? Scand J Infect Dis (1978) 0.78
Weekly malaria prophylaxis: 300 or 600 mg chloroquine base. Lancet (1979) 0.78
Low-dose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau. Trans R Soc Trop Med Hyg (2000) 0.77
Audiometry as a possible indicator of quinine plasma concentration during treatment of malaria. Trans R Soc Trop Med Hyg (1991) 0.77
Reversed-phase high-performance liquid chromatography determination of quinine in plasma, whole blood, urine, and samples dried on filter paper. Ther Drug Monit (1993) 0.77
Hearing impairment related to plasma quinine concentration in healthy volunteers. Br J Clin Pharmacol (1991) 0.77
Malaria prophylaxis with proguanil to Namibian refugee children in Angola. Trop Med Parasitol (1988) 0.77
In vivo response of Plasmodium falciparum to different doses of chloroquine in semi-immune children in Liberia, West Africa. Ann Trop Med Parasitol (1986) 0.76
Malaria control by chlorproguanil. I. Clinical effects and susceptibility of Plasmodium falciparum in vivo after seven years of monthly chlorproguanil administration to children in a Liberian village. Ann Trop Med Parasitol (1985) 0.76
Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop Med Parasitol (1987) 0.75
[Individualizing needed in aminoglycoside therapy]. Lakartidningen (1994) 0.75
[Severe injury and tetanus]. Lakartidningen (1994) 0.75
Norfloxacin is not effective for treatment of Plasmodium falciparum infection in Kenya. Trans R Soc Trop Med Hyg (1993) 0.75
Breakdown of mefloquine prophylaxis in central Africa. Scand J Infect Dis (1991) 0.75
[Fatal cases of malaria--preventive recommendations and information to travellers]. Lakartidningen (1991) 0.75
Clearance of plasmodium falciparum after reduced single daily doses of quinine in asymptomatic children in Guinea Bissau. Trop Med Parasitol (1991) 0.75
[Visceral leishmaniasis in 2 Swedish tourists after travel to Greece]. Lakartidningen (1986) 0.75
Evaluation of test sensitivity and test specificity of three field methods for quantification of chloroquine in urine using liquid chromatography as reference method. Ther Drug Monit (1990) 0.75
[Neurologic side effects of mefloquine. Implications for prevention and self administration]. Lakartidningen (1989) 0.75
Low doses of quinine during a short time period are effective for clearance of Plasmodium falciparum in asymptomatic children in Guinea Bissau. Trop Med Parasitol (1991) 0.75
[Malaria prevention--suggestions for recommendations]. Lakartidningen (1986) 0.75
[Drug prevention of malaria. No regime gives a complete protection]. Lakartidningen (1991) 0.75
[Analysis of feces is not sufficient in diagnosing giardiasis and amebiasis]. Lakartidningen (1990) 0.75
How safe is proguanil? A post-marketing investigation of side-effects. Scand J Infect Dis (1991) 0.75